Prime Biotech (India) Private Limited
About Prime Biotech (India) Private Limited
Data last updated:
Prime Biotech (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 07 September 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U01100MH2000PTC128573. Its GSTIN is 27AACCP4522B2ZV (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.7 Cr and a paid-up capital of ₹1.6 Cr. It is led by directors Mahesh Vijay Kachwal Sharma and Vishal Chaturvedi.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹75.08 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹56.94 Lakh (net margin 75.8%) and EBITDA of ₹67.88 Lakh (EBITDA margin 90.4%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Prime Biotech (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address82 Maker Chambers III 8th Floor, Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryReal Estate, Real Estate Leasing
To see the full contact details of Prime Biotech (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prime Biotech (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Prime Biotech (India) Private Limited
FY 2025 filings availablePrime Biotech (India) Private Limited reported revenue of ₹75.08 Lakh (up 165% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 165% growth in the latest year. EBITDA rose 215% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 90.4% | ||||
| Net Profit Margin | 75.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prime Biotech (India) Private Limited, buy the company report.
Board of directors of Prime Biotech (India) Private Limited
Prime Biotech (India) has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Vijay Kachwal Sharma Also directs: Key Builders Private Limited, Somerset Trading Private Limited, Kamakshi Tradings Co Pvt Ltd and 5 more | Director | 16 Feb 2023 | 3 Years 8 Months | Current |
| Vishal Chaturvedi Also directs: Somerset Trading Private Limited, Virram Properties Private Limited, Ridhi Synthetics Limited and 4 more | Director | 16 Feb 2023 | 3 Years 8 Months | Current |
Peer comparison
Prime Biotech (India) Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Formulae Healthcare Private Limited | ₹75.11 Lakh (FY 2024) | 83.0% | Vadodara, Gujarat, India | |||
| Anant Ceramics (I) Private Limited | ₹75.11 Lakh (FY 2025) | -76.0% | Hyderabad, Telangana, India | |||
| Austere Remedies Private Limited | ₹75.1 Lakh (FY 2025) | 2959.0% | Bhatpara, West Bengal, India | |||
| Prokrity Agrotec Private Limited | ₹75.1 Lakh (FY 2025) | 87.0% | Hooghly, West Bengal, India | |||
| Print Casual Brands Private Limited | ₹75.1 Lakh (FY 2025) | -7.0% | Noida, Uttar Pradesh, India | |||
| Prime Biotech (India) Private Limitedthis company | ₹75.08 Lakh (FY 2024) | ₹56.94 Lakh | 75.8% | 165.0% | Mumbai, Maharashtra, India | |
| Medisky Lifesciences Private Limited | ₹75.07 Lakh (FY 2025) | 165.0% | Patna, Bihar, India | |||
| Lenax Pharmaceuticals Private Limited | ₹75.07 Lakh (FY 2025) | 62.0% | Mumbai, Maharashtra, India | |||
| 3R Impex Fashion Private Limited | ₹75.06 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Ahemedabad Infrastructure Private Limited | ₹75.06 Lakh (FY 2025) | 145.0% | New Delhi, Delhi, India | |||
| Indoruss Synergy Private Limited | ₹75.06 Lakh (FY 2020) | 926518.0% | New Delhi, Delhi, India |
To see the full peer comparison of Prime Biotech (India) Private Limited, buy the company report.
Auditor
Prime Biotech (India) Private Limited is audited by H.H.BANDUKWALA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.H.BANDUKWALA & CO. | FY 2017 | 100965W |
Shareholding
The shareholding of Prime Biotech (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Prime Biotech (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Prime Biotech (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prime Biotech (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prime Biotech (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCP4522B2ZV | Maharashtra | Active | 31 Aug 2017 |
To see the full GST registrations and return filing status of Prime Biotech (India) Private Limited, buy the company report.
Recent activity
Prime Biotech (India) Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Mahesh Vijay Kachwal Sharma ceased to be Additional Director on 28 Sep 2023.
Frequently asked questions
Prime Biotech (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 07 September 2000 (26+ years old) and is registered under CIN U01100MH2000PTC128573.
Prime Biotech (India) has 2 current directors:
- Mahesh Vijay Kachwal Sharma - Director
- Vishal Chaturvedi - Director
The latest financial statements of Prime Biotech (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Prime Biotech (India) is 27AACCP4522B2ZV, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Prime Biotech (India) is U01100MH2000PTC128573. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prime Biotech (India) was incorporated on 07 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Prime Biotech (India) by revenue are Formulae Healthcare Private Limited, Anant Ceramics (I) Private Limited, Austere Remedies Private Limited, Prokrity Agrotec Private Limited, Print Casual Brands Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mahesh Vijay Kachwal Sharma ceased to be Additional Director on 28 Sep 2023. Vishal Chaturvedi ceased to be Additional Director on 28 Sep 2023. Manoj Sidhakaran Dadhich ceased to be Director on 04 Mar 2023. Prime Biotech (India) has 7 board changes on record in total.
The registered office of Prime Biotech (India) is at 82 Maker Chambers III 8th Floor, Nariman Point, Mumbai, Maharashtra, India – 400021.
Prime Biotech (India) operates in the real estate industry, in the real estate leasing segment.
The compliance status of Prime Biotech (India) is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.